ArticleBMJ open2024

Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non-valvular atrial fibrillation: protocol for a prospective, randomised, open-label, blinded endpoint trial (APIDP2).

Maxence Ficheux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.